Social media

As digital endpoints gain regulatory traction, sponsors who invest in endpoint strategy and validation today will be better positioned to run faster, more inclusive trials tomorrow. Digital health technologies are enabli...

Career progression is rarely linear, and there is no single path to leadership. In our latest blog, Sinéad McKeon discusses what drove her move from the lab bench to project management. She reflects on the capabilities...

Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe...

ICON provides comprehensive cardiac safety monitoring supported by a team of cardiovascular electrophysiology specialists, board certified cardiologists, radiologists, and medical experts. We offer protocol consulting,...

Looking forward to #ASCPT2026. Come along to the ICON partner hub for a chat and don’t miss our Learning Lab session on 5th March at 10:30 where we will be discussing considerations for the design, safety, pharmacokineti...

Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...

ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine have developed PLATO 11, a validated, patient centred PRO tool designed to better capture the lived experience of people with obstructive sleep a...

When patients lead, progress follows. Join ICON’s Centre for Rare Diseases for a special Rare Disease Day webinar exploring how patient and parent leaders are breaking barriers in ultra rare disease drug development. F...

Managing AI model biases in SaMD is no longer optional - it’s essential. As AI enabled medical devices accelerate through FDA authorisation, developers must ensure their models don’t unintentionally reinforce healthcare ...

Artificial intelligence is transforming how life sciences teams plan, execute, and scale commercial strategy—but the true differentiator isn’t the algorithm. It’s the data foundation behind it. In our latest blog, we ex...

The future of patient safety is being shaped today by experts who combine scientific rigour with innovation. Hassan Aljobori, Pharmacovigilance Director at ICON, discusses global collaboration, the role of emerging te...

Heart failure is one of the leading causes of hospitalisation among adults over 65. Cardiovascular outcome trials can be complex and costly. Find out how considering the human element of CVOTs, and building appropriate...